Cleared Traditional

K904748 - TRANSKINETICS INFRARED MULTI-LEAD TELE SYST 7100

K904748 is an FDA 510(k) clearance for TRANSKINETICS INFRARED MULTI-LEAD TELE ..., manufactured by Transtracheal Systems. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 133-day FDA review.

K904748 · Transtracheal Systems · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1991
Decision
133d
Days
Class 2
Risk

K904748 is an FDA 510(k) clearance for the TRANSKINETICS INFRARED MULTI-LEAD TELE SYST 7100. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Transtracheal Systems (Canton, US). The FDA issued a Cleared decision on March 1, 1991 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Transtracheal Systems devices

FDA 510(k) Submission Details - K904748

510(k) Number K904748 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 1990
Decision Date March 01, 1991
Days to Decision 133 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 80
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K904748.
NIHON KOHDEN ZB-821 TELEMETRY TRANSMITTER
K945578 · Nihon Kohden America, Inc. · Nov 1995
SIEMENS 1481 T TRANSMITTER, ENHANCED
K945037 · Siemens Medical Solutions USA, Inc. · Mar 1995
CARDIOCAP DR-124 RECORDER
K910620 · Datex Division Instrumentarium Corp. · May 1991
CD TELEMETRY SYSTEMS
K891104 · Marquette Electronics, Inc. · Apr 1989
MODEL 1010 PHYSIOLOGICAL SIGNAL TELEMETRY MONITOR
K873672 · Novametrix Medical Systems, Inc. · Dec 1987
ORG-7201 MULTIPARAMETER TELEMETRY MONITOR
K860239 · Nihon Kohden America, Inc. · Jun 1986